Quantcast
NTLA

NTLA Insider Activity (SEC Form 4)

$17.24
*  
0.23
1.35%
Get NTLA Alerts
*Delayed - data as of Nov. 15, 2018 11:34 ET  -  Find a broker to begin trading NTLA now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    NTLA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Number of Insider Trades


3 Mo. 12 Mo.
# of Open Market Buys 0 1
# of Sells 0 10
Total Insider Trades 0 11

Number of Insider Shares Traded


3 Mo. 12 Mo.
# of Shares Bought 0 410
# of Shares Sold 0 2,478,131
Total Shares Traded 0 2,478,541
Net Activity 0 (2,477,721)

Trades in last 3 months: 0
Trades in last 12 months: 11
The Summary totals only include Open Market Buys, the table below Includes all purchases.

Click on the column header links to resort ascending (▲) or descending (▼).


Insider Relation Last Date ▼ Transaction Type OwnerType Shares Traded Last Price Shares Held
FORMELA JEAN FRANCOIS Director 07/16/2018 Automatic Sell indirect 6,686 30.9680 1,615,321
FORMELA JEAN FRANCOIS Director 06/19/2018 Automatic Sell indirect 6,686 27.8400 1,836,810
FORMELA JEAN FRANCOIS Director 05/16/2018 Automatic Sell indirect 6,686 25.0358 2,058,299
LEONARD JOHN M. Officer 05/14/2018 Automatic Sell indirect 8,400 24.0000 58,415
BELL GRAEME Officer 03/28/2018 Option Execute direct 8,000 13.4800 21,400
DORSA CAROLINE Director 03/23/2018 Acquisition (Non Open Market) direct 410 24.0500 5,410
FORMELA JEAN FRANCOIS Director 03/20/2018 Sell indirect 39,245 23.7840 2,279,788
CARIBOU BIOSCIENCES, INC. Beneficial Owner (10%) 01/29/2018 Sell indirect 550,645 26.7800 3,994,355
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. Beneficial Owner (10%) 12/12/2017 Sell direct 1,523,000 18.3000 4,129,903
BERMINGHAM NESSAN Officer 12/08/2017 Automatic Sell direct 94,143 20.8210 458,250
BERMINGHAM NESSAN Officer 12/07/2017 Automatic Sell direct 131,140 21.0514 552,393
BERMINGHAM NESSAN Officer 12/06/2017 Automatic Sell direct 111,500 20.2780 683,533
BELL GRAEME Officer 11/03/2017 Acquisition (Non Open Market) direct 5,000 22.0433 13,400
CARIBOU BIOSCIENCES, INC. Beneficial Owner (10%) 09/13/2017 Sell indirect 1,048,846 4,545,000
ATLAS VENTURE FUND IX, L.P. Beneficial Owner (10%) 07/11/2017 Sell direct 80,000 16.0695 3,579,788

Insider Trading information for NTLA is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt of filing insider holdings with the SEC. Therefore, it is recommended to visit the company's website for up to date information.
info  Learn more about Insider Trades